company background image
ALPN logo

Alpine Immune Sciences NasdaqGM:ALPN 株式レポート

最終価格

US$64.97

時価総額

US$4.5b

7D

0.03%

1Y

518.2%

更新

21 May, 2024

データ

会社財務 +

Alpine Immune Sciences, Inc.

NasdaqGM:ALPN 株式レポート

時価総額:US$4.5b

Alpine Immune Sciences, Inc. 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめAlpine Immune Sciences
過去の株価
現在の株価US$64.97
52週高値US$65.00
52週安値US$8.33
ベータ0.97
11ヶ月の変化0.65%
3ヶ月変化113.79%
1年変化518.17%
33年間の変化520.53%
5年間の変化1,270.68%
IPOからの変化580.31%

最新ニュース

Recent updates

Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement

Apr 11

Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Mar 21
Earnings Update: Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Just Reported And Analysts Are Trimming Their Forecasts

Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation

Mar 20
Here's Why We're Not Too Worried About Alpine Immune Sciences' (NASDAQ:ALPN) Cash Burn Situation

Alpine Immune Sciences: Track Record Undermines Case For Latest Lead Drug

Mar 07

Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) Shares Climb 41% But Its Business Is Yet to Catch Up

Feb 07
Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) Shares Climb 41% But Its Business Is Yet to Catch Up

Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) 41% Share Price Surge Not Quite Adding Up

Dec 19
Alpine Immune Sciences, Inc.'s (NASDAQ:ALPN) 41% Share Price Surge Not Quite Adding Up

We Think Alpine Immune Sciences (NASDAQ:ALPN) Can Afford To Drive Business Growth

Sep 23
We Think Alpine Immune Sciences (NASDAQ:ALPN) Can Afford To Drive Business Growth

Revenues Not Telling The Story For Alpine Immune Sciences, Inc. (NASDAQ:ALPN)

May 11
Revenues Not Telling The Story For Alpine Immune Sciences, Inc. (NASDAQ:ALPN)

Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?

Dec 12
Is Alpine Immune Sciences (NASDAQ:ALPN) Weighed On By Its Debt Load?

Alpine Immune Sciences drops 13% after hours on $100M stock offering

Sep 20

Despite Lacking Profits Alpine Immune Sciences (NASDAQ:ALPN) Seems To Be On Top Of Its Debt

Aug 09
Despite Lacking Profits Alpine Immune Sciences (NASDAQ:ALPN) Seems To Be On Top Of Its Debt

Alpine: Rest Before Rallying Again

Apr 25

Is Alpine Immune Sciences (NASDAQ:ALPN) A Risky Investment?

Apr 12
Is Alpine Immune Sciences (NASDAQ:ALPN) A Risky Investment?

Rock star Growth Puts Alpine Immune Sciences (NASDAQ:ALPN) In A Position To Use Debt

Sep 18
Rock star Growth Puts Alpine Immune Sciences (NASDAQ:ALPN) In A Position To Use Debt

Industry Analysts Just Upgraded Their Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Revenue Forecasts By 42%

Aug 18
Industry Analysts Just Upgraded Their Alpine Immune Sciences, Inc. (NASDAQ:ALPN) Revenue Forecasts By 42%

株主還元

ALPNUS BiotechsUS 市場
7D0.03%-1.4%-1.9%
1Y518.2%20.2%30.4%

業界別リターン: ALPN過去 1 年間で20.2 % の収益を上げたUS Biotechs業界を上回りました。

リターン対市場: ALPN過去 1 年間で30.4 % の収益を上げたUS市場を上回りました。

価格変動

Is ALPN's price volatile compared to industry and market?
ALPN volatility
ALPN Average Weekly Movement13.8%
Biotechs Industry Average Movement9.6%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.9%

安定した株価: ALPNの株価は過去 3 か月間にわたって変動しています。

時間の経過による変動: ALPNの weekly volatility ( 14% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
2007142Mitch Goldwww.alpineimmunesciences.com

Alpine Immune Sciences, Inc. 基礎のまとめ

Alpine Immune Sciences の収益と売上を時価総額と比較するとどうか。
ALPN 基礎統計学
時価総額US$4.46b
収益(TTM)-US$36.84m
売上高(TTM)US$56.52m

78.9x

P/Sレシオ

-121.0x

PER(株価収益率

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
ALPN 損益計算書(TTM)
収益US$56.52m
売上原価US$83.78m
売上総利益-US$27.26m
その他の費用US$9.58m
収益-US$36.84m

直近の収益報告

Mar 31, 2024

次回決算日

該当なし

一株当たり利益(EPS)-0.54
グロス・マージン-48.23%
純利益率-65.17%
有利子負債/自己資本比率0%

ALPN の長期的なパフォーマンスは?

過去の実績と比較を見る